Following establishment of a syngeneic mouse model by subcutaneous inoculation of an HER3 overexpressing mouse melanoma cell line and successful tumour inhibition by the ADC, extensive evaluation of mechanisms of anti-tumour immunity were undertaken. The gene discussed is ERBB3; the disease is melanoma.